-
If your practice includes care of lesbian and bisexual women, and most practices do, dont dismiss taking their reproductive histories. New research indicates that previous pregnancy, induced abortion, and hormonal contraceptive use are common among women who report sex with women, regardless of whether they identify themselves as lesbian.
-
Checking your next patients chart, you see that the young woman uses depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City) for birth control. When you ask about her last injection, she tells you she missed her scheduled shot because she was out of town.
-
Clinicians who opt to use azithromycin for treatment of early syphilis should review recently published research that indicates that at least 10% of syphilis samples from patients at sexually transmitted disease (STD) clinics in four cities had a strain resistant to the antibiotic.
-
Mark your calendars for the Contraceptive Technology Quest for Excellence conference, set for Nov. 11-12 in Atlanta.
-
Your next patient is a 17-year-old who admits she has a hard time remembering to take the Pill, but says she wants to avoid unintended pregnancy. When you begin to counsel on the injectable contraceptive Depo Provera [depot medroxyprogesterone acetate (DMPA), Pfizer, New York City], what do you tell her about the drug?
-
If women could directly access hormonal contraception in pharmacies without a prescription, would they be interested in doing so, provided that pharmacists screen for the methods? A new survey indicates they would.
-
Which drugs might impact the efficacy of the birth control pill? Comments are offered by Andrew Kaunitz, MD, professor and assistant chair in the obstetrics and gynecology department at the University of Florida Health Science Center/Jacksonville, and Susan Wysocki, RNC, NP, president and chief executive officer of the National Association of Nurse Practitioners in Womens Health.
-
Put syphilis testing on your radar screen: Updated guidelines from the U.S. Preventive Services Task Force (USPSTF) recommend that health care providers perform syphilis screening on pregnant women and people who are at high risk for syphilis infection.
-
-
Until recently, an HIV and hepatitis C (HCV) coinfected patient who was managing well with HIV antiretrovirals might die from liver disease due to HCV infection. Now treatment has advanced, and the health prospects for coinfected patients are brighter than ever.
